×
EDAP TMS S.A Price to Free Cash Flow Ratio 2010-2024 | EDAP
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
EDAP TMS S.A price to free cash flow ratio from 2010 to 2024. Price to free cash flow ratio can be defined as
View More
EDAP TMS S.A Price to Free Cash Flow Ratio 2010-2024 | EDAP
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
EDAP TMS S.A price to free cash flow ratio from 2010 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$211B
Intuitive Surgical (ISRG)
$191.1B
Alcon (ALC)
$45.7B
IQVIA Holdings (IQV)
$39.8B
Edwards Lifesciences (EW)
$39.1B
IDEXX Laboratories (IDXX)
$35.5B
DexCom (DXCM)
$27.3B
Waters (WAT)
$22.8B
SONOVA HOLDING (SONVY)
$22.1B
STERIS (STE)
$21.6B
Hologic (HOLX)
$18.3B
Sysmex ADR (SSMXY)
$12.9B
Fresenius Medical Care AG KGaA (FMS)
$12.5B
Globus Medical (GMED)
$11B
Teleflex (TFX)
$9.1B
Penumbra (PEN)
$9.1B
Masimo (MASI)
$8.7B
Glaukos (GKOS)
$7.8B
PROCEPT BioRobotics (PRCT)
$5.2B
Integer Holdings (ITGR)
$4.6B
Inari Medical (NARI)
$3B
TransMedics (TMDX)
$2.9B
LivaNova (LIVN)
$2.8B
Veracyte (VCYT)
$2.8B
Nihon Kohden (NHNKY)
$2.6B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2B
Integra LifeSciences Holdings (IART)
$1.9B
RxSight (RXST)
$1.8B
Alphatec Holdings (ATEC)
$1.3B